| CML | Chronic Myeloid Leukemia |
| IFN-α | Interferon-alpha |
| Ph | Philadelphia |
| TKI | Tyrosine Kinase Inhibitor |
| Allo-HSCT | Allogeneic Stem Cell Transplantation |
| OS | Overall Survival |
| DMR | Deep Molecular Response |
| TFR | Treatment-Free Remission |
| QoL | Quality of Life |
| CV | Cardiovascular |
| CCyR | Complete Cytogenetic Response |
| RT-qPCR | Real-Time Quantitative Polymerase Chain Reaction |
| IS | International Scale |
| IRIS | International Randomized Study of Interferon and STI571 |
| MMR | Major Molecular Response |
| MR4 | Molecular Response with a 4-log Reduction |
| MR4.5 | Molecular Response with a 4.5-log Reduction |
| MR5 | Molecular Response with a 5-log Reduction |
| ELN | European LeukemiaNet |
| ACA | Additional Chromosomal Abnormality |
| ddPCR | Digital Droplet Polymerase Chain Reaction |
| NGS | Next-Generation Sequencing |
| LSCs | Leukemic Stem Cells |
| CVD | Cardiovascular Death |
| KD | Kinase Domain |